Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Ovarian Cancer Recurrent × poly(I).poly(c12,U) × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Neoplasm Metastasis 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

poly(I).poly(c12,U) 1 pembrolizumab 1 Paclitaxel 1 Lenalidomide 1 Interferon alpha-2 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03734692 2026-02-12

Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

University of Pittsburgh

Phase 1/2 Active not recruiting

24 enrolled 59 charts

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡